The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 12
Special Issue of the PrEP1519 Brazil Study
Cadernos de Saúde Pública released a special issue of the PrEP1519 study using baseline data. Click here more details. For a full breakdown of the free journal articles, please see below. Combination HIV prevention for adolescent men who have sex with men and adolescent transgender women in Brazil: vulnerabilities, access to healthcare, and expansion of…
Monitoring & Evaluation, Research
Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study
This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.
Travestis, Transgender Women and Young MSM are at High Risk for PrEP Early Loss to Follow-up in Rio de Janeiro, Brazil
This article from the Brazilian Journal of Infectious Diseases identifies factors associated with PrEP early loss to follow-up among gay, bisexual and other men who have sex with men, travestis, and transgender women in Rio de Janeiro, Brazil.
Monitoring & Evaluation, Service Delivery
Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A review and synthesis of the literature
This review from the journal AIDS and Behavior provides an examination of the influences of the COVID-19 pandemic on engagement in the PrEP care continuum, and looks at the barriers and facilitators to PrEP uptake during this time.
Research, Service Delivery
Transgender Women in HPTN 083: An evaluation of safety, efficacy, and gender affirming hormonal therapy interactions with long-acting cabotegravir
This poster from AIDS 2022 presents an analysis of results from the HPTN 083 study, looking at the impact of feminizing gender affirming hormones on cabotegravir (CAB) for PrEP pharmacokinetics.
Central America & Brazil Region ROP, 2022 (Español)
El objetivo del Plan Operativo Regional 2022 para la región de América Central y Brasil es mantener el progreso desde 2021 en áreas clave relacionadas con la promoción de la salud, como perfeccionar los esfuerzos para eliminar las barreras políticas, institucionalizar los servicios centrados en el cliente, ayudar al país a lograr 95-95 -95, y…
Central America & Brazil Region ROP, 2022
The goal of the 2022 Regional Operational Plan for the Central American & Brazil region is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, institutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations…
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study
This article from the Journal of the International AIDS Society assesses factors associated with long-term PrEP engagement and adherence among trans women enrolled in the Implementation of PrEP (ImPrEP) study, the largest PrEP demonstration study in Latin America.
The Brazilian government offers this monitoring panel which tracks national data on PrEP delivery.
Western Hemisphere & Brazil COP 2021
The goal of 2021 Country Operational Plan for the Western Hemisphere and Brazil is to maintain progress from 2020 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the countries under PEPFAR in the Western Hemisphere achieve 95-95-95, and spotlighting HIV prevention and treatment…